https://www.businesswire.com/news/home/20180724005288/en/

NEW YORK & WALTHAM, Mass.--(BUSINESS WIRE)--Jul 24, 2018--SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, announced today that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe.

Novartis will use the following SHYFT solutions: